Virbac S.A.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VRBCF research report →
Companycorporate.virbac.com
Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners.
- CEO
- Habib Ramdani
- IPO
- 2013
- Employees
- 6,365
- HQ
- Carros, FR
Price Chart
Valuation
- Market Cap
- $3.42B
- P/E
- 20.45
- P/S
- 2.10
- P/B
- 2.74
- EV/EBITDA
- 11.68
- Div Yield
- 0.40%
Profitability
- Gross Margin
- 35.36%
- Op Margin
- 14.89%
- Net Margin
- 10.30%
- ROE
- 13.78%
- ROIC
- 9.95%
Growth & Income
- Revenue
- $1.46B · 4.78%
- Net Income
- $150.83M · 3.81%
- EPS
- $17.98 · 3.63%
- Op Income
- $218.07M
- FCF YoY
- -16.49%
Performance & Tape
- 52W High
- $431.80
- 52W Low
- $346.00
- 50D MA
- $382.58
- 200D MA
- $355.14
- Beta
- 0.77
- Avg Volume
- 1
Get TickerSpark's AI analysis on VRBCF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our VRBCF Coverage
We haven't published any research on VRBCF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate VRBCF Report →